Roy Fleischmann Selected Research

Roy Fleischmann Research Topics

Disease

111	Rheumatoid Arthritis 04/2022 - 01/2002
23	Pain (Aches) 04/2022 - 03/2002
23	Infections 01/2022 - 01/2002
13	Fatigue 04/2022 - 08/2004
13	Psoriatic Arthritis 01/2021 - 01/2002
11	Necrosis 10/2020 - 01/2002
10	Chronic Disease (Chronic Diseases) 04/2022 - 03/2008
9	Herpes Zoster 01/2022 - 06/2014
8	Neoplasms (Cancer) 01/2022 - 01/2004
7	Ankylosing Spondylitis 11/2020 - 11/2003
7	Arthritis (Polyarthritis) 09/2020 - 07/2010
7	Rheumatic Diseases (Rheumatism) 04/2013 - 01/2002
5	Osteoarthritis 04/2022 - 10/2002
5	Tuberculosis (Tuberculoses) 01/2022 - 08/2004
5	Opportunistic Infections (Opportunistic Infection) 01/2022 - 08/2004
5	Injection Site Reaction 01/2014 - 01/2002
4	Inflammation (Inflammations) 06/2019 - 01/2006
3	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2020 - 01/2017
3	Disease Progression 08/2020 - 04/2007
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018 - 11/2003
3	Gout 01/2018 - 12/2014
3	Lymphoma (Lymphomas) 03/2015 - 05/2006
2	Anemia 04/2022 - 05/2012
2	Skin Neoplasms (Skin Cancer) 01/2022 - 01/2017
2	Atopic Dermatitis (Atopic Eczema) 11/2020 - 01/2006
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2020 - 05/2016
2	Urinary Tract Infections (Urinary Tract Infection) 01/2018 - 03/2012
2	Demyelinating Diseases (Demyelinating Disease) 03/2015 - 08/2004
2	Neutropenia 05/2012 - 05/2010
2	Diarrhea 05/2012 - 03/2012
2	Hypertension (High Blood Pressure) 05/2012 - 10/2002
1	Cutaneous Lupus Erythematosus 01/2022
1	Venous Thromboembolism 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	COVID-19 12/2021
1	Ulcerative Colitis 11/2020
1	Crohn Disease (Crohn's Disease) 11/2020
1	Breakthrough Infections 10/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 03/2020
1	Nasopharyngitis 01/2018
1	Pulmonary Embolism 01/2018
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2018

Drug/Important Bio-Agent (IBA)

50	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2002
31	tofacitinibIBA 01/2022 - 03/2012
27	Adalimumab (Humira)FDA Link 04/2022 - 01/2007
21	Antirheumatic Agents (DMARD)IBA 04/2022 - 01/2002
18	Janus Kinase InhibitorsIBA 01/2022 - 03/2012
17	Biological ProductsIBA 04/2022 - 07/2003
13	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 01/2004
12	ametantrone (HAQ)IBA 04/2022 - 11/2015
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2002
9	baricitinibIBA 01/2022 - 01/2017
8	Abatacept (Orencia)FDA Link 04/2022 - 01/2013
8	Certolizumab Pegol FDA Link 01/2018 - 01/2009
7	sarilumabIBA 11/2021 - 06/2015
6	upadacitinibIBA 02/2022 - 01/2018
6	GlucocorticoidsIBA 06/2020 - 05/2006
6	golimumab FDA Link 12/2016 - 07/2010
6	Etanercept (Enbrel)FDA Link 11/2014 - 01/2002
6	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 04/2007 - 01/2002
5	Monoclonal AntibodiesIBA 07/2021 - 01/2002
4	Adrenocorticotropic Hormone (ACTH)FDA Link 04/2022 - 06/2020
4	C-Reactive ProteinIBA 04/2022 - 01/2014
4	LipidsIBA 01/2022 - 05/2010
4	InterleukinsIBA 07/2021 - 01/2017
4	Rituximab (Mabthera)FDA Link 05/2011 - 05/2006
3	Phosphotransferases (Kinase)IBA 01/2022 - 05/2010
3	Interleukin-1 (Interleukin 1)IBA 01/2018 - 08/2004
3	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2017 - 01/2002
3	Pharmaceutical PreparationsIBA 01/2017 - 10/2002
3	Infliximab (Remicade)FDA Link 11/2014 - 01/2002
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 04/2007 - 01/2002
2	Anti-Citrullinated Protein AntibodiesIBA 04/2022 - 12/2019
2	Janus Kinase 1IBA 01/2022 - 01/2018
2	olokizumabIBA 07/2021 - 09/2014
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2020 - 01/2020
2	Janus KinasesIBA 10/2020 - 09/2018
2	Biosimilar PharmaceuticalsIBA 03/2020 - 01/2018
2	Uric Acid (Urate)IBA 01/2018 - 12/2014
2	Febuxostat FDA Link 01/2018 - 12/2014
2	verinuradIBA 01/2018 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2017
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2017 - 01/2002
2	CreatinineIBA 05/2012 - 05/2010
2	lumiracoxib (prexige)IBA 03/2008 - 02/2006
2	Celecoxib (Celebrex)FDA Link 03/2008 - 02/2006
2	Meloxicam (Mobic)FDA LinkGeneric 10/2002 - 03/2002
2	Diclofenac (SR 38)FDA LinkGeneric 10/2002 - 03/2002
1	Hemoglobins (Hemoglobin)IBA 04/2022
1	acetyl 4-aminosalicylic acidIBA 04/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	GLPG0634IBA 01/2022
1	5-(tetradecyloxy)-2-furancarboxylic acid (TOFA)IBA 11/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2020
1	Herpes Zoster VaccineIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Creatine Kinase (Creatine Phosphokinase)IBA 11/2019

Therapy/Procedure

35	Therapeutics 04/2022 - 01/2004
4	Biological Therapy 05/2012 - 01/2009
2	Aftercare (After-Treatment) 12/2016 - 11/2015